133 results
8-K
EX-99.1
RGEN
Repligen Corp.
27 Feb 20
Repligen Appoints Rohin Mhatre, Ph.D. to Board of Directors
7:43am
responsibility leading to his current position of Senior Vice President, Product and Technology Development. Dr. Mhatre’s previous roles with Biogen … include Vice President of Biopharmaceutical Development, where he led a300-member team with responsibility for cell line, cell culture, purification
8-K
EX-99.1
RGEN
Repligen Corp.
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
CFO role, Mr. Garland will act as a key partner to the business, with responsibility for all corporate finance and audit functions, capital markets … responsibility at GE. His rotations and achievements at GE culminated in several leadership positions including his last, aforementioned role as CFO for GE
8-K
EX-99.1
RGEN
Repligen Corp.
1 Jun 22
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
5:25pm
responsibility leading to his role as Head of Process Science. Dr. Konstantinov earned his Ph.D. from Osaka University, with a focus on Biochemical Engineering … from time to time in our filings with the Securities and Exchange Commission. We expressly disclaim any responsibility to update any forward-looking
8-K
EX-99.1
RGEN
Repligen Corp.
15 Jul 14
Departure of Directors or Certain Officers
12:00am
of Finance for the Laboratory Products Group. At both Maquet and Thermo Fisher, Mr. Snodgres held key responsibility for numerous acquisitions … company.”
Mr. Snodgres joined Maquet Cardiovascular as CFO in 2009. There, in addition to P&L, balance sheet and cash flow responsibility, he was a key
8-K
EX-99.1
RGEN
Repligen Corp.
15 Jun 20
Repligen Appoints Carrie Eglinton Manner to Board of Directors
7:36am
and responsibility over a period of 20 years at GE Healthcare (NYSE:GE). From 2009 through 2016, she served as President & CEO of four distinct GE Healthcare global … and Exchange Commission. We expressly disclaim any responsibility to update any forward-looking statements, except as required by law.
Repligen
8-K/A
EX-99.2
23fmaf7786akvn ggsv
29 Apr 19
Other Events
4:09pm
8-K
EX-99.1
407mk5x2vfg6sy
2 Oct 23
Repligen Appoints Olivier Loeillot As President and Chief Commercial Officer
7:42am
8-K/A
EX-99.5
760h19
15 Jul 19
Other Events
4:02pm
DEFR14A
chy52of1q 9di
5 May 21
Revised proxy
4:16pm
8-K
EX-99.1
bi79ix3nmdv ig769yf
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
424B7
u54w5sx4 cy
5 Nov 21
Prospectus with selling stockholder info
4:16pm
10-K
EX-10.41
3581siff0rdlhv8 x1
17 Jul 95
Annual report
12:00am
S-3ASR
2l44k3bjxzz15 32i9ny
29 Apr 19
Automatic shelf registration
4:15pm